Abstract
BackgroundStudies combining immunosuppressive biologics have shown an increased risk of infections.ObjectivesExamine the occurrence of serious and opportunistic infections in RA patients treated concurrently with DMAb and an immunosuppressive biologic, and...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
